Altered levels of the soluble IL-1, IL-4 and TNF receptors, as well as the IL-1 receptor antagonist, in intermittent allergic rhinitis

被引:16
|
作者
Benson, M [1 ]
Wennergren, G
Fransson, M
Cardell, LO
机构
[1] Queen Silvia Childrens Hosp, Pediat Allergy Res Grp, SE-41685 Gothenburg, Sweden
[2] Lund Univ, Malmo Univ Hosp, Dept Otorhinolaryngol, Lab Clin & Expt Allergol, Malmo, Sweden
关键词
cytokines; soluble; interleukins; receptors; rhinitis;
D O I
10.1159/000078770
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Background: The effects of cytokines are modulated by soluble cytokine receptors (SCR) and receptor antagonists. Therefore, allergic disease may depend on altered proportions between cytokines, their SCR and receptor antagonists, rather than absolute changes in cytokine levels. Little is known about SCR in intermittent allergic rhinitis (IAR). Objective: To examine the concentrations of SCR, i.e. sIL-1R2, sIL-4R, sIL-6R and sTNFR1, as well as the interleukin-1 receptor antagonist (IL-1Ra) in nasal fluids from allergen-challenged patients with IAR and healthy controls. Methods: 30 patients with birch- or grass-pollen-induced IAR and 30 healthy controls were studied. In the patients nasal fluids were obtained before as well as 1 and 6 h after allergen provocation. Results: Both symptom scores and rhinoscopic signs of rhinitis increased in the patients after allergen challenge. Comparisons between patients and controls showed that sIL-4R was lower in patients before and 1 and 6 h after provocation. IL-1Ra was lower before and 1 h after provocation. In addition, lower concentrations of sTNFR1 were found in patients after 1 h, while sIL-1R2 concentrations were higher after 1 h. Comparisons of patients before and after challenge showed that IL-1Ra and sTNFR1 decreased after 1 h, while sIL-1R2 increased. No significant differences were found compared to 6 h. sIL-6R did not significantly differ between the study groups. Conclusions: After allergen challenge, significant changes in the nasal fluid levels of IL-1Ra, sIL-1R2 and sTNFR1 were found. By contrast, sIL-4R remained at lower levels than in controls both before and after challenge. Since sIL-4R modulates IgE synthesis, this may play a role in the pathogenesis of IAR. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:227 / 232
页数:6
相关论文
共 50 条
  • [1] BINDING OF IL-1-ALPHA, IL-1-BETA, AND IL-1 RECEPTOR ANTAGONIST BY SOLUBLE IL-1 RECEPTORS AND LEVELS OF SOLUBLE IL-1 RECEPTORS IN SYNOVIAL-FLUIDS
    AREND, WP
    MALYAK, M
    SMITH, MF
    WHISENAND, TD
    SLACK, JL
    SIMS, JE
    GIRI, JG
    DOWER, SK
    [J]. JOURNAL OF IMMUNOLOGY, 1994, 153 (10): : 4766 - 4774
  • [2] IL-4 RECIPROCALLY REGULATES IL-1 AND IL-1 RECEPTOR ANTAGONIST EXPRESSION IN HUMAN MONOCYTES
    FENTON, MJ
    BURAS, JA
    DONNELLY, RP
    [J]. JOURNAL OF IMMUNOLOGY, 1992, 149 (04): : 1283 - 1288
  • [3] The IL-1 system in HIV infection: Peripheral concentrations of IL-1 beta, IL-1 receptor antagonist and soluble IL-1 receptor type II
    Kreuzer, KA
    Dayer, JM
    Rockstroh, JK
    Sauerbruch, T
    Spengler, U
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1997, 109 (01): : 54 - 58
  • [4] DIFFERENTIAL GENE-EXPRESSION FOR IL-1 RECEPTOR ANTAGONIST, IL-1, AND TNF RECEPTORS AND IL-1 AND TNF SYNTHESIS MAY EXPLAIN IL-1-INDUCED RESISTANCE TO INFECTION
    VOGELS, MTE
    MENSINK, EJBM
    YE, K
    BOERMAN, OC
    VERSCHUEREN, CMM
    DINARELLO, CA
    VANDERMEER, JWM
    [J]. JOURNAL OF IMMUNOLOGY, 1994, 153 (12): : 5772 - 5780
  • [5] IL-1β, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders
    Tominaga, K
    Habu, M
    Sukedai, M
    Hirota, Y
    Takahashi, T
    Fukuda, J
    [J]. ARCHIVES OF ORAL BIOLOGY, 2004, 49 (06) : 493 - 499
  • [6] Concentrations of interleukin (IL)-1α, IL-1 soluble receptor type II (IL-1 sRII) and IL-1 receptor antagonist (IL-1 Ra) in the peritoneal fluid and serum of infertile women with endometriosis
    Kondera-Anasz, Z
    Sikora, J
    Mielczarek-Palacz, A
    Jonca, M
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2005, 123 (02) : 198 - 203
  • [7] SOLUBLE RECEPTORS FOR IL-1 AND IL-4 - BIOLOGICAL-ACTIVITY AND THERAPEUTIC POTENTIAL
    MALISZEWSKI, CR
    FANSLOW, WC
    [J]. TRENDS IN BIOTECHNOLOGY, 1990, 8 (11) : 324 - 329
  • [8] Roles of IL-1 and IL-1 receptor antagonist in the immune system
    Horai, R
    Asano, M
    Nakae, S
    Saijo, S
    Sudo, K
    Iwakura, Y
    [J]. EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 380 - 380
  • [9] HUMAN AND BOVINE IL-1 RECEPTORS DISCRIMINATE BETWEEN HOMOLOGOUS AND HETEROLOGOUS IL-1 BUT NOT THE HUMAN IL-1 RECEPTOR ANTAGONIST (IL-1RA)
    LEDERER, J
    CZUPRYNSKI, C
    [J]. FASEB JOURNAL, 1991, 5 (05): : A1341 - A1341
  • [10] The levels of IL-1β and soluble IL-1 receptors in patients with IgG4-related periaortitis/periarteritis
    Ashihara, Norihiro
    Ota, Masao
    Fujinaga, Yasunari
    Ozawa, Makiko
    Kuraishi, Yasuhiro
    Watanabe, Takayuki
    Hamano, Hideaki
    Joshita, Satoru
    Kawa, Shigeyuki
    Umemura, Takeji
    [J]. ADVANCES IN MEDICAL SCIENCES, 2022, 67 (02): : 257 - 261